Aflac Earnings: An Early Look
With hundreds of companies having already reported quarterly results, we're now in the heart of earnings season. The key to making smart investment decisions with stocks releasing their reports is to anticipate how they'll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you'll be less likely to make an uninformed knee-jerk reaction to news.
Let's turn to Aflac . The insurance giant is best known for its duck ads in the U.S., but the bulk of its business comes from risk-averse Japan. Let's take an early look at what's been happening with Aflac over the past quarter and what we're likely to see in its quarterly report Tuesday.
Stats on Aflac
Analyst EPS Estimate
Change From Year-Ago EPS
Change From Year-Ago Revenue
Earnings Beats in Past 4 Quarters
Source: Yahoo! Finance.
Can Aflac insure success for investors?
Analysts have largely stuck by their initial estimates of Aflac's earnings for the quarter, cutting their earnings-per-share calls by only a couple pennies. The stock has managed to climb about 5% since early November.
The big difference that Aflac enjoys compared to many insurers is that its losses are both geographically diversified and different in kind from typical property and casualty coverage. For instance, Travelers and Allstate both suffered severe losses from Hurricane Sandy, even though Travelers' stock rebounded after its quarterly report revealed that those losses weren't as bad as initially expected. By contrast, Aflac's primary focus on supplemental life and health insurance in the U.S. leaves it largely unaffected by all but the worst natural disasters, and its business ends up being relatively stable by comparison.
One long-term question the company has to address is how the Affordable Care Act will affect its supplemental health policies going forward. UnitedHealth , WellPoint , and other primary health-insurance providers are looking forward to the individual mandate to bring in new customers, and they could be able to poach customers who currently rely on Aflac's supplements rather than having full-blown health coverage of their own. Aflac will have to work hard to retain those customers and seek out new ones from among the newly covered ranks.
With three decades of consistent dividend growth, Aflac just needs to convince investors that business as usual is continuing to reap rewards. If its report Tuesday shows that, then Aflac should please shareholders with its numbers.
Health care investing is hot again
Obamacare has caused huge rumbles throughout the health-insurance industry. But is Obamacare an investing opportunity for insurance stocks? Find out in our brand-new premium report on UnitedHealth, where we take the long-term view, homing in on prospects for UnitedHealth and its peers in a post-Obamacare world. The report also comes with a full year of analyst updates to keep you covered as key news develops, so don't miss out -- simply click here now to claim your copy today.
Click here to add Aflac to My Watchlist, which can find all of our Foolish analysis on it and all your other stocks.
The article Aflac Earnings: An Early Look originally appeared on Fool.com.Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool recommends Aflac, UnitedHealth Group, and WellPoint. The Motley Fool owns shares of WellPoint. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.